Park Ha Biological Technology Co., Ltd. (PHH) Stock Analysis

Park Ha Biological Technology Co., Ltd. (PHH) is a publicly traded company in the CONSUMER DEFENSIVE sector. It trades at $0.39. This page summarizes the public market data, fundamentals, and frequently asked questions for PHH, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: CONSUMER DEFENSIVE - HOUSEHOLD & PERSONAL PRODUCTS

Exchange: NASDAQ

Key Metrics

• Price: $0.39

Market Sentiment

Park Ha Biological Technology Co., Ltd. currently has a Neutral sentiment score of 0.04.

About Park Ha Biological Technology Co., Ltd.

PHH Corporation, based in Mount Laurel, New Jersey, is a premier provider of residential mortgage sub-servicing solutions in the United States, operating through its subsidiary, PHH Mortgage Corporation. The company excels in delivering comprehensive mortgage servicing capabilities, leveraging cutting-edge technology to optimize operational efficiency and elevate customer experience. With a strong portfolio and a steadfast commitment to regulatory compliance and risk management, PHH is strate...

GNG Research Analysis

GNG Research scores Park Ha Biological Technology Co., Ltd. (PHH) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for PHH.

Frequently Asked Questions

Does PHH pay dividends?

Park Ha Biological Technology Co., Ltd. (PHH) does not currently pay a regular dividend.